▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1488 by analyst upside · 2026-08-13
IRTC
iRhythm Holdings, Inc.
Healthcare · Market Cap $4B · P/E 0x
ANALYST PRICE TARGET
+41.1%
implied upside to consensus target
Current Price $125.35
Consensus Target $176.86
Bull Target $200.0
Bear Target $157.0
Analysts Covering 14
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
12
Hold
0
Sell
0
52-Week Low $100.85
52-Week High $212.0
YTD Return -28.5%
FUNDAMENTALS
Market Cap $4B
P/E Ratio (TTM) N/A
Forward P/E 105.0x
EPS (TTM) $-0.41
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $825M
Profit Margin -1.7%
52-WEEK RANGE
52-Week Low $100.85
52-Week High $212.0
Current Price $125.35
Bear Target $157.0
Bull Target $200.0
● Now $125.35 ● Target $176.86
TRADING DATA
Avg Volume 603K
YTD Return -28.5%
Analyst Count 14
Consensus Buy
Upside to Target +41.1%
Last Updated 2026-08-13

ANALYST SUMMARY

iRhythm Holdings, Inc. (IRTC) is currently trading at $125.35 with a Wall Street consensus price target of $176.86, implying potential upside of 41.1% over the next 12 months. 14 analysts currently cover IRTC, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $200.0, while the most cautious has a target of $157.0.

IRTC operates in the Healthcare sector with a market capitalisation of $4B. The stock is down 28.5% year-to-date and is currently trading near the lower end of its 52-week range of $100.85 – $212.0.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

INDV +26.5%
Indivior Pharmaceuticals, Inc.
$5B · P/E 13.9x · Buy
GRFS +37.0%
Grifols, S.A.
$5B · P/E 10.4x · Buy
OPCH +19.9%
Option Care Health, Inc.
$4B · P/E 18.1x · Buy
ACAD +13.8%
ACADIA Pharmaceuticals Inc.
$5B · P/E 13.2x · Buy
CON +11.8%
Concentra Group Holdings Parent, Inc.
$4B · P/E 21.3x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for IRTC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

BTIG reit
Buy → Buy 2026-06-10 38% win rate (8 calls)
Canaccord Genuity - Reiterated
Buy → Buy 2026-06-01 Building track record
B of A Securities - Reiterated
Buy → Buy 2026-05-18 Building track record
Citigroup - Reiterated
Buy → Buy 2026-05-04 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2026-05-01 Building track record
JP Morgan - Reiterated
Overweight → Overweight 2026-05-01 43% win rate (7 calls)
Wells Fargo - Reiterated
Overweight → Overweight 2026-05-01 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-05-01 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
71
out of 100
Coverage depth
21/30
Consensus clarity
23/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →